Sunitinib Malate
Product Images NDC 16714-676

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Sunitinib Malate (NDC 16714-676). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rxllc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Spl-sunitinib-northstar-12.5 mg Label (Spl Sunitinib Northstar 12.5 mg Label.jpg.jpg)

Label for Sunitinib Malate Capsules 12.5 mg by NorthStar RxLLC. The label shows the product name, strength, dosage form, and quantity of 28 capsules. It includes a barcode, serialization area, and mentions pharmacist dispensing instructions and storage conditions.*

FDA Label Image

Spl-sunitinib-northstar-25 mg Label (Spl Sunitinib Northstar 25 mg Label)

Label for Sunitinib Malate Capsules 25 mg from NorthStar RxLLC, featuring product name, strength, dosage form, and package size of 28 capsules. The label includes NDC number, instructions for pharmacists, barcode, serialization space, and storage information.*

FDA Label Image

Spl-sunitinib-northstar-37.5 mg Label (Spl Sunitinib Northstar 37.5 mg Label.jpg.jpg)

Sunitinib Malate Capsules 37.5 mg label from NorthStar RxLLC. The label indicates a package containing 28 capsules. It includes dosage strength, storage instructions, and a barcode with a space for serialization. Additional coding fields for GTIN, lot number, expiration, and serial number are noted for online batch coding details.*

FDA Label Image

Spl-sunitinib-northstar-50 mg Label (Spl Sunitinib Northstar 50 mg Label)

Packaging label for Sunitinib Malate Capsules 50 mg, manufactured by NorthStar RxLLC, containing 28 capsules. The label includes dosage information, storage instructions, barcode, and space for serialization details.*

FDA Label Image

Spl-sunitinib-northstar-figure-1 (Spl Sunitinib Northstar Figure 1)

A Kaplan-Meier survival curve chart showing tumor progression probability (%) over time (weeks) comparing Sunitinib and placebo groups. The chart illustrates longer median time to tumor progression for the Sunitinib group (27.3 weeks) versus placebo (6.4 weeks), with accompanying statistical data including hazard ratio and p-value.*

FDA Label Image

Spl-sunitinib-northstar-figure-2 (Spl Sunitinib Northstar Figure 2)

A Kaplan-Meier survival curve chart showing progression-free survival probability over time (weeks) comparing Sunitinib and IFN-α treatment groups. The chart includes hazard ratio and confidence interval, median survival weeks for each group, and number of subjects at risk at various time points.*

FDA Label Image

Spl-sunitinib-northstar-figure-4 (Spl Sunitinib Northstar Figure 4)

A Kaplan-Meier survival curve chart depicting progression-free survival probability over time in months for Sunitinib and placebo groups. The chart compares survival probabilities with Sunitinib showing a median of 10.2 months and placebo 5.4 months, including hazard ratio and confidence interval statistics.*

FDA Label Image

Spl-sunitinib-northstar-molecular Structure (Spl Sunitinib Northstar Molecular Structure)

Chemical structure of sunitinib malate, showing the detailed arrangement of atoms including fluorine, nitrogen, oxygen, and carbon in the molecular framework. The structure includes the malate moiety connected to the sunitinib core.*

FDA Label Image

Spl-sunitinib-northstar-figure 3 (Spl Sunitinib Northstar Figure 3)

A Kaplan-Meier survival curve chart showing disease-free survival probability (%) over time in years, comparing Sunitinib (N=309) and placebo (N=306). The graph includes median survival times (6.8 years for Sunitinib, 5.6 years for placebo), number of subjects at risk at various times, and a hazard ratio of 0.76 with 95% confidence interval and p-value of 0.03.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.